Even in Denmark — Novo Nordisk's property market place — an application for Wegovy to receive general public health insurance policy coverage was turned down around the grounds that its cost was incommensurate with its therapeutic value.Amongst our healthcare professionals will cautiously evaluate this data and may then Get hold of you to even